Global Dry Eye Syndrome Market Overview: 2024-2030
Base Year: 2023
Historical Years: 2019-22
Forecast Years: 2024-2030
The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html
Global Dry Eye Syndrome Market Dynamics: 2024-2030
Global Dry Eye Syndrome Market Driver:
Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.
Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years..
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html
Global Dry Eye Syndrome Market (2024-30): Segmentation Outlook
The market report has segmented the market into the following categories:
By Product
-Artificial Tears- Market Size & Forecast 2019-2030, USD Million
-Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
-Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
-Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
-Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
-Dissolvable-- Market Size & Forecast 2019-2030, USD Million
-Removable-- Market Size & Forecast 2019-2030, USD Million
-Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million
Anti-inflammatory drugs are among the most prevailing treatments for dry eye disease & have a high contribution in expanding the market size
By Disease Type
-Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
-Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million
By Distribution Channel
-Offline- Market Size & Forecast 2019-2030, USD Million
-Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
-Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
-Online- Market Size & Forecast 2019-2030, USD Million
By Competition
-Competition Characteristics
-Market Share Analysis
By Region
-North America
-South America
-Europe
-Middle East & Africa
-Asia-Pacific.
Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Global Dry Eye Syndrome Market:
-Mitotech Pharma
-ReGen Tree
-Santen Pharmaceutical
-HanAll BioPharma
-Sun Pharma
-Novaliq
-Sylentis
-Alcon.
Industry Recent Development:
- 2023: Novaliq & Bosch+Laumb announced the publication of pivotal phase 3 data of their ophthalmic drug NOVO3, which is developed to treat the signs & symptoms of Dry Eye Disease associated with meibomian gland dysfunction.
- 2022: Santen Pharmaceutical launched its dry-eye treatment DIQUAS® LX Ophthalmic Solution in Japan, which is an improved formulation to reduce administration frequency to three times daily & ease the patient burden.
Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India